Archive for the ‘Actos’ Category
France, Germany Suspend Takeda's Actos On Bladder Cancer Risk
Written by on June 10, 2011actos While the FDA continues to review the Takeda Pharmaceuticals diabetes drug for bladder cancer risks, French regulators are suspending use of the pill, as well as Takeda's Competact, after reviewing I could even see some patients preferring a monthly injection over daily pills like Merck's (NYSE: MRK ) Januvia and Takeda's Actos. But alas, [...]
Read the rest of this entry »